Clinical Trial Update: Testosterone Effects on Men With the Metabolic Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the effects of testosterone in men with metabolic syndrome has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome

Drugs mentioned

• TESTOSTERONE (testosterone)

Snippet

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Conditions: Metabolic Syndrome | Phase 2 | Status: WITHDRAWN